<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>Pathology, Department of</title>
<link>http://hdl.handle.net/2027.42/78399</link>
<description/>
<pubDate>Thu, 20 Jun 2013 11:52:37 GMT</pubDate>
<dc:date>2013-06-20T11:52:37Z</dc:date>
<image>
<title>Pathology, Department of</title>
<url>http://deepblue.lib.umich.edu:80/bitstream/id/279992/216680.gif</url>
<link>http://hdl.handle.net/2027.42/78399</link>
</image>
<item>
<title>Pitting Function of the Spleen in Malaria: Ultrastructural Observations</title>
<link>http://hdl.handle.net/2027.42/98426</link>
<description>Pitting Function of the Spleen in Malaria: Ultrastructural Observations
Schnitzer, Bertram
Ultrastructural studies of spleens from monkeys infected with Plasmodium knowlesi suggest that the spleen removes or "pits" malaria parasites from red cells.  This function may explain the presence of nonparasitized spherocytic erythrocytes in the peripheral blood and may in part account for the discrepancy between the excessive hemolysis and the number of parasitized erythrocytes in animals with experimentally induced malaria.
Cover of "Science"; Cover --article
</description>
<pubDate>Fri, 14 Jul 1972 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/2027.42/98426</guid>
<dc:date>1972-07-14T00:00:00Z</dc:date>
</item>
<item>
<title>Lean Six Sigma to reduce blood wastage</title>
<link>http://hdl.handle.net/2027.42/83241</link>
<description>Lean Six Sigma to reduce blood wastage
Mandell, Steven
</description>
<pubDate>Wed, 01 Sep 2010 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/2027.42/83241</guid>
<dc:date>2010-09-01T00:00:00Z</dc:date>
</item>
<item>
<title>An analysis of antiseptic and antibiotic properties of variously treated mosses and lichen.</title>
<link>http://hdl.handle.net/2027.42/78342</link>
<description>An analysis of antiseptic and antibiotic properties of variously treated mosses and lichen.
Morton, Elaine; Winters, Josh; Smith, Lauren
Lichen, a symbiosis between algae and fungus, and sphagnum moss are both able to fight against bacteria. In this experiment, we tested whether moss and lichen have antibiotic or antiseptic properties on human-affecting bacteria, and to find out which types of mosses and lichen have the strongest of these properties. We collected samples of fruticose lichen, foliose lichen, crustose lichen, red sphagnum moss (Sp. 1) and green sphagnum moss (Sp. 2) from Bryant Bog and placed them into 160 Petri dishes with bacteria. We also recorded the pH of each type, to see if it had a relationship with bacterial growth. Although pH was not found to be related to antiseptic and antibiotic properties, treatments of each taxon were found to make a difference in the inhibition of bacterial growth. The abilities lichen and sphagnum moss to fight off bacteria were determined after they were plated for five days with gram-positive bacteria in an incubator at 35C. From our test, we were able to draw the conclusion that fruticose, when crushed, was a strong antibiotic compound, and ground green sphagnum moss (Sp. 2) was a strong antiseptic compound.
General Ecology
</description>
<pubDate>Fri, 01 Jan 2010 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/2027.42/78342</guid>
<dc:date>2010-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden</title>
<link>http://hdl.handle.net/2027.42/78314</link>
<description>Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden
O'Leary, John C III; Li, Qingyou; Marinec, Paul; Blair, Laura J; Congdon, Erin E; Johnson, Amelia G; Jinwal, Umesh K; Koren, John III; Jones, Jeffrey R; Kraft, Clara; Peters, Melinda; Abisambra, Jose F; Duff, Karen E; Weeber, Edwin J; Gestwicki, Jason E; Dickey, Chad A
Abstract Background It has traditionally been thought that the pathological accumulation of tau in Alzheimer's disease and other tauopathies facilitates neurodegeneration, which in turn leads to cognitive impairment. However, recent evidence suggests that tau tangles are not the entity responsible for memory loss, rather it is an intermediate tau species that disrupts neuronal function. Thus, efforts to discover therapeutics for tauopathies emphasize soluble tau reductions as well as neuroprotection. Results Here, we found that neuroprotection alone caused by methylene blue (MB), the parent compound of the anti-tau phenothiaziazine drug, Rember&amp;#8482;, was insufficient to rescue cognition in a mouse model of the human tauopathy, progressive supranuclear palsy (PSP) and fronto-temporal dementia with parkinsonism linked to chromosome 17 (FTDP17): Only when levels of soluble tau protein were concomitantly reduced by a very high concentration of MB, was cognitive improvement observed. Thus, neurodegeneration can be decoupled from tau accumulation, but phenotypic improvement is only possible when soluble tau levels are also reduced. Conclusions Neuroprotection alone is not sufficient to rescue tau-induced memory loss in a transgenic mouse model. Development of neuroprotective agents is an area of intense investigation in the tauopathy drug discovery field. This may ultimately be an unsuccessful approach if soluble toxic tau intermediates are not also reduced. Thus, MB and related compounds, despite their pleiotropic nature, may be the proverbial "magic bullet" because they not only are neuroprotective, but are also able to facilitate soluble tau clearance. Moreover, this shows that neuroprotection is possible without reducing tau levels. This indicates that there is a definitive molecular link between tau and cell death cascades that can be disrupted.
</description>
<pubDate>Mon, 01 Nov 2010 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/2027.42/78314</guid>
<dc:date>2010-11-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
